EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access

Assessing the Utility, Impact, and Adoption Challenges of an Artificial Intelligence–Enabled Prescription Advisory Tool for Type 2 Diabetes Management: Qualitative Study

Sungwon Yoon iD, Hendra Goh iD, Phong Ching Lee iD, Hong Chang Tan iD, Ming Ming Teh iD, Dawn Shao Ting Lim iD, Ann Kwee iD, Chandran Suresh iD, David Carmody iD, Du Soon Swee iD, Sarah Ying Tse Tan iD, Andy Jun-Wei Wong iD und 3 weitere

JMIR Human Factors · 13.06.2024 · 11 · e50939

DOI: 10.2196/50939 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift JMIR Human Factors, online erschienen am 13.06.2024. Verfasst von Sungwon Yoon und 14 weiteren Autor:innen. Beteiligte Einrichtung: Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Artificial Intelligence, Focus Groups, Qualitative Research. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical management of type 2 diabetes mellitus (T2DM) presents a significant challenge due to the constantly evolving clinical practice guidelines and growing array of drug classes available. Evidence suggests that artificial intelligence (AI)–enabled clinical decision support systems (CDSSs) have proven to be effective in assisting clinicians with informed decision-making. Despite the merits of AI-driven CDSSs, a significant research gap exists concerning the early-stage implementation and adoption of AI-enabled CDSSs in T2DM management.

Objective

This study aimed to explore the perspectives of clinicians on the use and impact of the AI-enabled Prescription Advisory (APA) tool, developed using a multi-institution diabetes registry and implemented in specialist endocrinology clinics, and the challenges to its adoption and application.

Methods

We conducted focus group discussions using a semistructured interview guide with purposively selected endocrinologists from a tertiary hospital. The focus group discussions were audio-recorded and transcribed verbatim. Data were thematically analyzed.

Results

A total of 13 clinicians participated in 4 focus group discussions. Our findings suggest that the APA tool offered several useful features to assist clinicians in effectively managing T2DM. Specifically, clinicians viewed the AI-generated medication alterations as a good knowledge resource in supporting the clinician’s decision-making on drug modifications at the point of care, particularly for patients with comorbidities. The complication risk prediction was seen as positively impacting patient care by facilitating early doctor-patient communication and initiating prompt clinical responses. However, the interpretability of the risk scores, concerns about overreliance and automation bias, and issues surrounding accountability and liability hindered the adoption of the APA tool in clinical practice.

Conclusions

Although the APA tool holds great potential as a valuable resource for improving patient care, further efforts are required to address clinicians’ concerns and improve the tool’s acceptance and applicability in relevant contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Artificial IntelligenceFocus GroupsQualitative ResearchHumansDecision Support Systems, ClinicalMaleFemaleHypoglycemic AgentsMiddle AgedAdult

Stichwörter der Autor:innen

artificial intelligenceclinical decision support systemdiabetes managementendocrinologyhuman factors

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.
  • Centre for Population Health Research and Implementation, SingHealth Regional Health System, SingHealth, Singapore, Singapore.
  • Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.

ORCID-Profile: Sungwon Yoon, Hendra Goh, Phong Ching Lee, Hong Chang Tan, Ming Ming Teh, Dawn Shao Ting Lim, Ann Kwee, Chandran Suresh, David Carmody, Du Soon Swee, Sarah Ying Tse Tan, Andy Jun-Wei Wong, Charlotte Hui-Min Choo, Zongwen Wee, Yong Mong Bee

Zitieren

APA

Yoon, S., Goh, H., Lee, P. C., Tan, H. C., Teh, M. M., Lim, D. S. T., Kwee, A., Suresh, C., Carmody, D., Swee, D. S., Tan, S. Y. T., Wong, A. J., Choo, C. H., Wee, Z., & Bee, Y. M. (2024). Assessing the Utility, Impact, and Adoption Challenges of an Artificial Intelligence–Enabled Prescription Advisory Tool for Type 2 Diabetes Management: Qualitative Study. JMIR Human Factors, 11, e50939. https://doi.org/10.2196/50939

Vancouver

Yoon S, Goh H, Lee PC, Tan HC, Teh MM, Lim DST, et al. Assessing the Utility, Impact, and Adoption Challenges of an Artificial Intelligence–Enabled Prescription Advisory Tool for Type 2 Diabetes Management: Qualitative Study. JMIR Human Factors. 2024;11:e50939. doi:10.2196/50939

BibTeX
@article{Yoon2024,
  author = {Yoon, Sungwon and Goh, Hendra and Lee, Phong Ching and Tan, Hong Chang and Teh, Ming Ming and Lim, Dawn Shao Ting and Kwee, Ann and Suresh, Chandran and Carmody, David and Swee, Du Soon and Tan, Sarah Ying Tse and Wong, Andy Jun-Wei and Choo, Charlotte Hui-Min and Wee, Zongwen and Bee, Yong Mong},
  title = {Assessing the Utility, Impact, and Adoption Challenges of an Artificial Intelligence–Enabled Prescription Advisory Tool for Type 2 Diabetes Management: Qualitative Study},
  journal = {JMIR Human Factors},
  year = {2024},
  volume = {11},
  pages = {e50939},
  doi = {10.2196/50939}
}
Kostenlos starten →